“A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer’s disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings featuring the drug, Dimebon, are published in the journal The Lancet.” (ScienceDaily.com)

Leave a Reply